A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells

DNA and Cell Biology

Volumn 23, Issue 7, 2004, Pages 419-429

  Xu, Yong ^a   Fang, Fang ^a   Ludewig, Gabriele ^b   Jones, Grace ^a   Jones, Davy ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SURVIVIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; TRANSCRIPTION INITIATION;

BASE SEQUENCE; BINDING SITES; CELL CYCLE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 3242748276     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/1044549041474788     Document Type: Article

References (44)

1. ADIDA, C., BERREBI, D., PEUCHMAUR, M., REYES-MUGICA, M., and ALTIERI, D.C. (1998). Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351, 882-883.
2. ALTIERI, D.C. (2001). The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med. 7, 542-547.
3. ALTIERI, D.C., and MARCHISIO, C. (1999). Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab. Invest. 79, 1327-1333.
4. ALTUCCI, L., and GRONEMEYER, H. (2001). Nuclear receptors in cell life and death. Trends Endocrinol. Metabol. 12, 461-468.
5. AMBROSINI, G., ADIDA, C., SIRUGO, G., and ALTIERI, D.C. (1998). Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem. 273, 11177-11182.
6. BRANDEIS, M., and HUNT, T. (1996). The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J. 15, 5280-5289.
7. CHEN, J. (2000). Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2, 235-241.
8. CLEM, R.J., and DUCKETT, C.S. (1997). The iap genes: Unique arbitrators of cell death. Trends Cell Biol. 7, 337-339.
9. DOHNA, L.C., BRANDEIS, M., BERR, F., MOSSNER, J., and ENGELAND, K. (2000). CDE/CHR tandem element regulates cell cycle-dependent repression of cyclin B2 transcription. FEBS Lett. 484, 77-81.
10. FAJAS, L., LE CAM, L., POLANOWSKA, J., FABBRIZIO, E., SERVANT, N., PHILIPS, A., CARNAC, G., and SARDET, C. (2000). A CDE/CHR-like element mediates repression of transcription of the mouse RB2 (p130) gene. FEBS Lett. 477, 29-33.
11. GROSSMAN, D., KIM, P.J., BLANC-BRUDE, O.P., BRASH, D.E., TOGNIN, S., MARCHISIO, P.C., and ALTIERI, D.C. (2001). Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 108, 991-999.
12. GROSSMAN, D., MCNIFF, J.M., LI, F., and ALTIERI, D.C. (1999). Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest. Dermatol. 113, 1076-1081.
13. HATTORI, M., SAKAMOTO, H., SATOH, K., and YAMAMOTO, T. (2001). DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett. 169, 155-164.
14. HELIN, K., LEES, J.A., VIDAL, M., DYSON, N., HARLOW, E., and FATTAEY, A. (1992). A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70, 337-350.
15. ITO, T., SHIRAKI, K., SUGIMOTO, K., YAMANAKA, T., FUJIKAWA, K., ITO, M., TAKASE, K., MORIYAMA, M., KAWANO, H., HAYASHIDA, M., et al. (2000). Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31, 1080-1085.
16. LEES, E.M., and HARLOW, E. (1995). Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and inactivation of Cdc 2 kinase. Cell 81, 149-152.
17. LI, F., and ALTIERI, D.C. (1999a). Transcriptional analysis of human survivin gene expression. Biochem. J. 344, 305-311.
18. LI, F., and ALTIERI, D.C. (1999b). The cancer antiapoptosis mouse survivin gene: Characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res. 59, 3143-3151.
19. LI, F., ACKERMANN, E.J., BENNETT, C.F., ROTHERMEL, A.L., PLESCIA, J., TOGNIN, S., VILLA, A., MARCHISIO, P.C., and ALTIERI, D.C. (1999). Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1, 461-466.
20. LI, F., AMBROSINI, G., CHU, E.Y., PLESCIA, J., TOGNIN, S., MARCHISIO, P.C., and ALTIERI, D.C. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
21. LIU, N., LUCIBELIO, F. C., KÖRNER, K., WOLFRAIM, L. A., ZWICKER, J., and MÜLLER, R. (1997). CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters. Nucleic Acids Res. 24, 4915-4920.
22. MESRI, M., WALL, N.R., LI, J., KIM, R.W., and ALTIERI, D.C. (2001). Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 108, 981-990.
23. MICHALIDES, R., VAN TINTEREN, H., BALKENENDE, A., VERMORKEN, J.B., BENRAADT, J., HULDIJ, J., and VAN DIEST, P. (2002). Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment. Br. J. Cancer 86, 402-408.
24. MUZIO, L.L., STAIBANO, S., PANNONE, G., MIGNOGNA, M.D., MARIGGÒ, A., SALVATORE, G., CHIEFFI, P., TRAMONTANO, D., DEROSE, G., and ALRIERI, D.C. (2001). Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp. Mol. Pathol. 70, 249-254.
25. NURSE, P. (1990). Universal control mechanism regulating onset of M-phase. Nature 344, 503-507.
26. NURSE, P. (1994) Ordering S phase and M phase in the cell cycle. Cell 79, 547-550.
27. OLIE, R.A., SIMÕES-WÜST, P.A., BAUMANN, B., LEECH, S.H., FABBRO, D., STAHEL, R.A., and ZANGEMEISTER-WITTKE, U. (2001). A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizing lung cancer cells to chemotherapy. Cancer Res. 60, 2805-2809.
28. O'CONNOR, S. GROSSMAN, D., PLESCIA, J., LI, F., ZHANG, H., VILLA, A., TOGNIN, S., MARCHISIO, P.C., and ALTIERI, D.C. (2000). Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 97, 13103-13107.
29. OTAKI, M., HATANO, M., KOBAYASHI, K., OGASAWARE, T., KURIYAMA, T., and TOKUHISA, T. (2000). Cell cycle-dependent regulation of TIAP/m-survivin expression. Biochi. Biophys. Acta, 1493, 188-194.
30. PETER, M., and HERSKOWITZ, I. (1994). Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79, 181-184.
31. PHILIPS, A., CHAMBEYRON, S., LAMB, N., VIÉ, A., and BLANCHARD, J.M. (1999). CHF: A novel factor binding to cyclin A CHR corepressor element. Oncogene 18, 6222-6232.
32. REED, J.C., and BISCHOFF, J.R. (2000). BIRinging chromosomes through cell division - And survivin' the experience. Cell 102, 545-548.
33. ROHAYEM, J. DIESTELKOETTER, P., WEIGLE, B., OEHMICHEN, A., SCHEHMITZ, M., MEHLHORN, J., CONRAD, K., and RIEBER, E.P. (2000). Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res. 60, 1815-1817.
34. SARAFAN-VASSEUR, N., LAMY, A., BOURGUIGNON, J., PESSOT, F.L., HIETER, F., SESBOÜÉ, R., BASTARD, C., FRÉBOURG, T., and FLAMAN, J.-M. (2002). Overexpression of B-type cyclins alters chromosomal segregation. Oncogene 21, 2051-2057.
35. SHERR, C.J. (1994). G1 phase progression: Cycling on cue. Cell 79, 551-555.
36. SONG, Z., YAO, X., and WU, M. (2003). Direct interaction between survivin and Smac/Diablo is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J. Biol. Chem. 278, 23130-23140.
37. SUZUKI, A., ITO, T., KAWANO, H., HAYASHIDA, M., HAYASAKI, Y., TSUTOMI, T., AKAHANA, K., NAKANO, T., MIURA, M., and SHIRAKI, K. (2000). Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19, 1346-1353.
38. TAKAHASHI, Y., RAYMAN, J.B., and DYNLACHT, B.D. (2000). Analysis of promoter binding by rhe E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev. 14, 804-816.
39. TAMM, I., WANG, Y., SAUSVILLE, E., SCUDIERO, D.A., VIGNA, N., OLTERSDORF, T., and REED, J.C. (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, Caspases, and anticancer drugs. Cancer Res. 58, 5315-5320.
40. UCHIUMI, T., LONGO, D.L., and FERRIS, D.K. (1997). Cell cycle regulation of the human polo-like kinase (PLK) promoter. J. Biol. Chem. 272, 9166-9174.
41. UREN, A.G. WONG, L., PAKUSCH, M., FOWLER, K.J., BURROWS, F.J., VAUX, D.L., and CHOO, K.H.A. (2000). Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr. Biol. 10, 1319-1328.
42. ZHAO, J., TENEV, T., MARTINS, L.M., DOWNWARD, J., and LEMOINE, N.R. (2000). The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell Sci. 113, 4363-4371.
43. ZWICKER, J., GROSS, C., LUCIBELLO, F., TRUSS, M., EHLERT, F., ENGELAND, K., and MULLER, R. (1995a). Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res. 23, 3822-3830.
44. ZWICKER, J., LUCIBELLO, F.C., WOLFRAIM, L.A., GROSS, C., TRUSS, M., ENGELAND, K., and MULLER, R. (1995b). Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J. 14, 4514-4522.